Debra Yu

COO & Partner at Panacea Capital

Speaker

Debra Yu currently serves as Chief Operating Officer and Partner at Panacea Capital. She has nearly 4 decades of experience as an investor, strategist, investment banker and business development executive. She is widely known for her cross-border China expertise. She also serves as a Board Member at MeiraGTx Holdings PLC (NASDAQ: MGTX), Ascentage Pharma (NASDAQ: AAPGV/HKG: 6855) and JW (Cayman) Therapeutics Co Ltd (HKG: 2126). Her prior roles include Founding President of Lianbio, Managing Director and Head of Cross Border Healthcare Investment Banking at China Renaissance Securities (U.S.), Managing Director of Labrador Advisors, and Team Leader for Pfizer Venture Investments. She has held other positions at Bay City Capital, Delphi Ventures, McKinsey and Morgan Stanley. She received a bachelor's degree with high honors in molecular biology from Princeton University and earned her medical degree from Harvard Medical School.